Improvement in the clinical manifestations of interstitial lung disease following treatment with placental mesenchymal stromal cell extracellular vesicles in a patient with systemic sclerosis: A case report

Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to investigate the effectiveness of treatment with placental mesenchymal stromal cell (MSC) extracellular vesicles (EVs) in a patient with ILD due...

Full description

Saved in:
Bibliographic Details
Published inRespiratory medicine case reports Vol. 46; p. 101923
Main Authors Assar, Shirin, Mohammadzadeh, Dena, Norooznezhad, Amir Hossein, Payandeh, Mehrdad, Hassaninia, Daryoush, Pournazari, Mehran, Soufivand, Parviz, Yarani, Reza, Mansouri, Kamran
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.01.2023
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to investigate the effectiveness of treatment with placental mesenchymal stromal cell (MSC) extracellular vesicles (EVs) in a patient with ILD due to SSc. The patient was a 55-year-old woman with a ten years history of SSc complicated by severe ILD. Over time, her lung disease progressed to interstitial fibrosis despite being treated with mycophenolate mofetil and monthly pulses of cyclophosphamide. Thus, she was treated with eight doses of placenta MSC-EVs. Four weeks after the third dose (Day 31 after the first dose), she reported marked improvement in her clinical symptoms, such as dyspnea and cough. Also, chest computed tomography (CT) scans demonstrated a significant reduction in ground glass consolidations and fibrotic changes. The patient was subsequently followed for twelve months, with findings showing significant improvement in exercise tolerance and reduced supplemental oxygen need. In this single case, placental MSC-EVs were seen to provide a potentially efficient treatment for SSc-related ILD; however, further investigation and clinical trials are necessary.
AbstractList Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to investigate the effectiveness of treatment with placental mesenchymal stromal cell (MSC) extracellular vesicles (EVs) in a patient with ILD due to SSc. The patient was a 55-year-old woman with a ten years history of SSc complicated by severe ILD. Over time, her lung disease progressed to interstitial fibrosis despite being treated with mycophenolate mofetil and monthly pulses of cyclophosphamide. Thus, she was treated with eight doses of placenta MSC-EVs. Four weeks after the third dose (Day 31 after the first dose), she reported marked improvement in her clinical symptoms, such as dyspnea and cough. Also, chest computed tomography (CT) scans demonstrated a significant reduction in ground glass consolidations and fibrotic changes. The patient was subsequently followed for twelve months, with findings showing significant improvement in exercise tolerance and reduced supplemental oxygen need. In this single case, placental MSC-EVs were seen to provide a potentially efficient treatment for SSc-related ILD; however, further investigation and clinical trials are necessary.
Background: Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to investigate the effectiveness of treatment with placental mesenchymal stromal cell (MSC) extracellular vesicles (EVs) in a patient with ILD due to SSc. Case presentation: The patient was a 55-year-old woman with a ten years history of SSc complicated by severe ILD. Over time, her lung disease progressed to interstitial fibrosis despite being treated with mycophenolate mofetil and monthly pulses of cyclophosphamide. Thus, she was treated with eight doses of placenta MSC-EVs. Four weeks after the third dose (Day 31 after the first dose), she reported marked improvement in her clinical symptoms, such as dyspnea and cough. Also, chest computed tomography (CT) scans demonstrated a significant reduction in ground glass consolidations and fibrotic changes. The patient was subsequently followed for twelve months, with findings showing significant improvement in exercise tolerance and reduced supplemental oxygen need. Conclusion: In this single case, placental MSC-EVs were seen to provide a potentially efficient treatment for SSc-related ILD; however, further investigation and clinical trials are necessary.
ArticleNumber 101923
Author Norooznezhad, Amir Hossein
Soufivand, Parviz
Payandeh, Mehrdad
Pournazari, Mehran
Hassaninia, Daryoush
Assar, Shirin
Mohammadzadeh, Dena
Yarani, Reza
Mansouri, Kamran
Author_xml – sequence: 1
  givenname: Shirin
  surname: Assar
  fullname: Assar, Shirin
  organization: Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
– sequence: 2
  givenname: Dena
  surname: Mohammadzadeh
  fullname: Mohammadzadeh, Dena
  organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
– sequence: 3
  givenname: Amir Hossein
  surname: Norooznezhad
  fullname: Norooznezhad, Amir Hossein
  organization: Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
– sequence: 4
  givenname: Mehrdad
  surname: Payandeh
  fullname: Payandeh, Mehrdad
  organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
– sequence: 5
  givenname: Daryoush
  surname: Hassaninia
  fullname: Hassaninia, Daryoush
  organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
– sequence: 6
  givenname: Mehran
  surname: Pournazari
  fullname: Pournazari, Mehran
  organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
– sequence: 7
  givenname: Parviz
  surname: Soufivand
  fullname: Soufivand, Parviz
  organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
– sequence: 8
  givenname: Reza
  surname: Yarani
  fullname: Yarani, Reza
  organization: Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
– sequence: 9
  givenname: Kamran
  surname: Mansouri
  fullname: Mansouri, Kamran
  email: kmansouri@kums.ac.ir, kamranmansouri@gmail.com
  organization: Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
BookMark eNp9kttq3DAQQE1JoWmaH-iTfmC3utiyXQolhF4WAn1pn8VYHu9qkSUjaTfdn8w3VcqGkLxULzOay5kL8766cN5hVX1kdM0ok5_26zDrsOaUi2LouXhTXXLOxIrSll280N9V1zHuaX5t19OGX1YPm3kJ_ogzukSMI2mHRFvjjAZLZnBmwpggGe8i8VOOSBhiMslktz24LRlNRIhIJm-tvzfZkgJCeuTdm7QjiwWdPwWHEZ3eneasxxR8kRqtJfg3BSjawUIgR4xGW4ylHSBLLv7MiqeYcDaaxBwQfDTxM7khutQPuPiQPlRvJ7ARr5_kVfXn-7fftz9Xd79-bG5v7la6ljKtGOBABWUtBZScD4I1om8HNlE5yVHItq6xG9saJcpxaJpWDDWn4wAdayZALq6qzZk7etirJZgZwkl5MOrR4MNWQUhlDCVYi81Yi6ajGav7HvgwdL0UuqNMS5ZZX8-s5TDMOJZlBbCvoK89zuzU1h8Vo7n3TvaZwM8EnXcSA07PyYyqciJqr8qJqHIi6nwiOenLOQnzno4Gg4o6b1rjaALqlAcx_0v_B-WizeE
CitedBy_id crossref_primary_10_1002_jev2_12433
crossref_primary_10_1136_ard_2023_224092
Cites_doi 10.3389/fcell.2021.600711
10.1007/s13770-021-00405-5
10.1111/jcmm.17114
10.1136/ard.60.6.577
10.1056/NEJMra0806188
10.3390/ijms20184337
10.1016/j.jaut.2021.102660
10.1016/j.jaut.2016.03.013
10.1016/j.rdc.2015.04.003
10.1016/j.autrev.2021.102978
10.1155/2019/4506303
ContentType Journal Article
Copyright 2023 The Authors
2023 The Authors 2023
Copyright_xml – notice: 2023 The Authors
– notice: 2023 The Authors 2023
DBID 6I.
AAFTH
AAYXX
CITATION
5PM
DOA
DOI 10.1016/j.rmcr.2023.101923
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2213-0071
ExternalDocumentID oai_doaj_org_article_317e5d43580744c99a2bb8963c801c61
10_1016_j_rmcr_2023_101923
S2213007123001181
GroupedDBID .1-
.FO
0R~
0SF
1B1
1P~
1~5
457
4G.
53G
5VS
6I.
7-5
AACTN
AAEDT
AAEDW
AAFTH
AAIKJ
AALRI
AAXUO
ABMAC
ACGFS
ADBBV
ADEZE
ADRAZ
AEVXI
AEXQZ
AFCTW
AFRHN
AFTJW
AGHFR
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BCNDV
DIK
EBS
EJD
EO9
EP2
EP3
FDB
GROUPED_DOAJ
HYE
HZ~
IPNFZ
IXB
KQ8
M41
M48
M~E
NCXOZ
O-L
O9-
RIG
ROL
RPM
SES
SSZ
XH2
Z5R
AAYXX
ADVLN
AFJKZ
AKRWK
CITATION
5PM
ID FETCH-LOGICAL-c466t-1aeb030170ae622b315397b1f06f6d36744e8d74e6e6db5573b420dba815fae23
IEDL.DBID RPM
ISSN 2213-0071
IngestDate Tue Oct 22 15:13:29 EDT 2024
Tue Sep 17 21:29:33 EDT 2024
Thu Sep 26 17:11:29 EDT 2024
Sat Oct 14 15:51:05 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Mesenchymal stromal cells
Extracellular vesicles
Interstitial lung disease
Systemic sclerosis
Language English
License This is an open access article under the CC BY-NC-ND license.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c466t-1aeb030170ae622b315397b1f06f6d36744e8d74e6e6db5573b420dba815fae23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622869/
ParticipantIDs doaj_primary_oai_doaj_org_article_317e5d43580744c99a2bb8963c801c61
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10622869
crossref_primary_10_1016_j_rmcr_2023_101923
elsevier_sciencedirect_doi_10_1016_j_rmcr_2023_101923
PublicationCentury 2000
PublicationDate 2023-01-01
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-01
  day: 01
PublicationDecade 2020
PublicationTitle Respiratory medicine case reports
PublicationYear 2023
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Vonk, Smith, Sfikakis, Cutolo, Del Galdo, Seibold (bib2) 2021; 20
Rozier, Maumus, Maria, Toupet, Lai-Kee-Him, Jorgensen (bib5) 2021; 121
Colletti, Galardi, De Santis, Guidelli, Di Giannatale, Di Luigi (bib3) 2019; 20
Yu, Shen, Xie, Zhao, Jiang (bib7) 2021; 19
Binks, Passweg, Furst, McSweeney, Sullivan, Besenthal (bib12) 2001; 60
Norooznezhad, Yarani, Payandeh, Hoseinkhani, Kiani, Taghizadeh (bib9) 2022; 26
Abreu, Lopes-Pacheco, Weiss, Rocco (bib11) 2021; 9
Gabrielli, Avvedimento, Krieg (bib1) 2009; 360
Pope, Johnson (bib8) 2015; 41
Maria, Toupet, Maumus, Fonteneau, Le Quellec, Jorgensen (bib4) 2016; 70
de la Torre, Pérez-Lorenzo, Flores (bib10) 2019
Sun, Zhu, Feng, Lin, Yin, Jin (bib6) 2019; 2019
Maria (10.1016/j.rmcr.2023.101923_bib4) 2016; 70
Gabrielli (10.1016/j.rmcr.2023.101923_bib1) 2009; 360
Abreu (10.1016/j.rmcr.2023.101923_bib11) 2021; 9
de la Torre (10.1016/j.rmcr.2023.101923_bib10) 2019
Binks (10.1016/j.rmcr.2023.101923_bib12) 2001; 60
Norooznezhad (10.1016/j.rmcr.2023.101923_bib9) 2022; 26
Vonk (10.1016/j.rmcr.2023.101923_bib2) 2021; 20
Rozier (10.1016/j.rmcr.2023.101923_bib5) 2021; 121
Colletti (10.1016/j.rmcr.2023.101923_bib3) 2019; 20
Yu (10.1016/j.rmcr.2023.101923_bib7) 2021; 19
Pope (10.1016/j.rmcr.2023.101923_bib8) 2015; 41
Sun (10.1016/j.rmcr.2023.101923_bib6) 2019; 2019
References_xml – volume: 60
  start-page: 577
  year: 2001
  end-page: 584
  ident: bib12
  article-title: Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
  publication-title: Ann. Rheum. Dis.
  contributor:
    fullname: Besenthal
– volume: 26
  start-page: 588
  year: 2022
  end-page: 592
  ident: bib9
  article-title: Human placental mesenchymal stromal cell-derived exosome-enriched extracellular vesicles for chronic cutaneous graft-versus-host disease: a case report
  publication-title: J. Cell Mol. Med.
  contributor:
    fullname: Taghizadeh
– volume: 360
  start-page: 1989
  year: 2009
  end-page: 2003
  ident: bib1
  publication-title: Scleroderma. N. Engl. J. Med.
  contributor:
    fullname: Krieg
– volume: 70
  start-page: 31
  year: 2016
  end-page: 39
  ident: bib4
  article-title: Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis
  publication-title: J. Autoimmun.
  contributor:
    fullname: Jorgensen
– volume: 20
  year: 2021
  ident: bib2
  article-title: Pharmacological treatments for SSc-ILD: systematic review and critical appraisal of the evidence
  publication-title: Autoimmun. Rev.
  contributor:
    fullname: Seibold
– volume: 20
  start-page: 4337
  year: 2019
  ident: bib3
  article-title: Exosomes in systemic sclerosis: messengers between immune, vascular and fibrotic components?
  publication-title: Int. J. Mol. Sci.
  contributor:
    fullname: Di Luigi
– volume: 2019
  year: 2019
  ident: bib6
  article-title: Exosomal miRNA Let-7 from menstrual blood-derived endometrial stem cells alleviates pulmonary fibrosis through regulating mitochondrial DNA damage
  publication-title: Oxid. Med. Cell. Longev.
  contributor:
    fullname: Jin
– volume: 19
  start-page: 141
  year: 2021
  end-page: 150
  ident: bib7
  article-title: The therapeutic effects of exosomes derived from human umbilical cord mesenchymal stem cells on scleroderma
  publication-title: Tissue. Eng. Regen. Med.
  contributor:
    fullname: Jiang
– volume: 41
  start-page: 383
  year: 2015
  end-page: 398
  ident: bib8
  article-title: New classification criteria for systemic sclerosis (scleroderma)
  publication-title: Rheum. Dis. Clin. N. Am.
  contributor:
    fullname: Johnson
– start-page: 300
  year: 2019
  end-page: 302
  ident: bib10
  article-title: Human placenta-derived mesenchymal stromal cells: a review from basic research to clinical applications
  publication-title: Stromal Cells Structure, Function, and Therapeutic Implications
  contributor:
    fullname: Flores
– volume: 121
  year: 2021
  ident: bib5
  article-title: Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p
  publication-title: J. Autoimmun.
  contributor:
    fullname: Jorgensen
– volume: 9
  year: 2021
  ident: bib11
  article-title: Mesenchymal stromal cell-derived extracellular vesicles in lung diseases: current status and perspectives
  publication-title: Front. Cell Dev. Biol.
  contributor:
    fullname: Rocco
– volume: 9
  year: 2021
  ident: 10.1016/j.rmcr.2023.101923_bib11
  article-title: Mesenchymal stromal cell-derived extracellular vesicles in lung diseases: current status and perspectives
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2021.600711
  contributor:
    fullname: Abreu
– volume: 19
  start-page: 141
  issue: 1
  year: 2021
  ident: 10.1016/j.rmcr.2023.101923_bib7
  article-title: The therapeutic effects of exosomes derived from human umbilical cord mesenchymal stem cells on scleroderma
  publication-title: Tissue. Eng. Regen. Med.
  doi: 10.1007/s13770-021-00405-5
  contributor:
    fullname: Yu
– volume: 26
  start-page: 588
  issue: 2
  year: 2022
  ident: 10.1016/j.rmcr.2023.101923_bib9
  article-title: Human placental mesenchymal stromal cell-derived exosome-enriched extracellular vesicles for chronic cutaneous graft-versus-host disease: a case report
  publication-title: J. Cell Mol. Med.
  doi: 10.1111/jcmm.17114
  contributor:
    fullname: Norooznezhad
– volume: 60
  start-page: 577
  issue: 6
  year: 2001
  ident: 10.1016/j.rmcr.2023.101923_bib12
  article-title: Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/ard.60.6.577
  contributor:
    fullname: Binks
– volume: 360
  start-page: 1989
  issue: 19
  year: 2009
  ident: 10.1016/j.rmcr.2023.101923_bib1
  publication-title: Scleroderma. N. Engl. J. Med.
  doi: 10.1056/NEJMra0806188
  contributor:
    fullname: Gabrielli
– volume: 20
  start-page: 4337
  issue: 18
  year: 2019
  ident: 10.1016/j.rmcr.2023.101923_bib3
  article-title: Exosomes in systemic sclerosis: messengers between immune, vascular and fibrotic components?
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20184337
  contributor:
    fullname: Colletti
– volume: 121
  year: 2021
  ident: 10.1016/j.rmcr.2023.101923_bib5
  article-title: Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p
  publication-title: J. Autoimmun.
  doi: 10.1016/j.jaut.2021.102660
  contributor:
    fullname: Rozier
– volume: 70
  start-page: 31
  year: 2016
  ident: 10.1016/j.rmcr.2023.101923_bib4
  article-title: Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis
  publication-title: J. Autoimmun.
  doi: 10.1016/j.jaut.2016.03.013
  contributor:
    fullname: Maria
– volume: 41
  start-page: 383
  issue: 3
  year: 2015
  ident: 10.1016/j.rmcr.2023.101923_bib8
  article-title: New classification criteria for systemic sclerosis (scleroderma)
  publication-title: Rheum. Dis. Clin. N. Am.
  doi: 10.1016/j.rdc.2015.04.003
  contributor:
    fullname: Pope
– start-page: 300
  year: 2019
  ident: 10.1016/j.rmcr.2023.101923_bib10
  article-title: Human placenta-derived mesenchymal stromal cells: a review from basic research to clinical applications
  contributor:
    fullname: de la Torre
– volume: 20
  issue: 12
  year: 2021
  ident: 10.1016/j.rmcr.2023.101923_bib2
  article-title: Pharmacological treatments for SSc-ILD: systematic review and critical appraisal of the evidence
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2021.102978
  contributor:
    fullname: Vonk
– volume: 2019
  year: 2019
  ident: 10.1016/j.rmcr.2023.101923_bib6
  article-title: Exosomal miRNA Let-7 from menstrual blood-derived endometrial stem cells alleviates pulmonary fibrosis through regulating mitochondrial DNA damage
  publication-title: Oxid. Med. Cell. Longev.
  doi: 10.1155/2019/4506303
  contributor:
    fullname: Sun
SSID ssj0000789052
Score 2.2933812
Snippet Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to...
Background: Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This...
SourceID doaj
pubmedcentral
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Publisher
StartPage 101923
SubjectTerms Case Report
Extracellular vesicles
Interstitial lung disease
Mesenchymal stromal cells
Systemic sclerosis
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9RAEG5kD-JFfOL4og7eJJj0K4m3VVwWYT25sLfQjwobcTKSjIp_0t9kVbpnmVz04iUJSUgXqUq964sQr5xqaiyjKjTWtAlRF01lYqG0UaWrfbAtzztffLLnl_rjlbk6-tUX94QleOD04t6QfUMTNVfraq1D2zrpfUNiE0i3hhz4VOYomFp0MM93GpmnZFJD17QNDAAqFZ9opVpZogWwf2WQ1j2SR0bn7J64m71FOE1U3he3cHwgbl_kevhD8TvlBJYUHwwjkDcHh1lHYGSLHudUa59h1wNjQ0zcHEBCB1_pM4dcn4GexGH3k8wY3HSeA6doYenZ4olJ2PKcUrj-taXjeT_teM9pfyD1Pjk-4o5W-IHz0mnH5DjIsK3pWQk1eggw0w30Tob5LZxC4PVT6eKRuDz78Pn9eZH_0FAEbe2-qBx6jqnq0qGV0ivSn23tq760vY3KEsewibVGizZ6Y2rltSyjdyQPvUOpHouTcTfiEwFVXUWtvUZnKCJEbMoWQ-x9CFY5Utkb8frAre5bAuLoDh1qXzrmbce87RJvN-IdM_TmTgbRXk6QaHVZtLp_idZGmIM4dNkfSX4GPWr46-LNSnZWVKyvjMP1AulNgbmUjW2f_g-6n4k7TE1KFD0XJ_vpO74g12nvXy5fyR_KjB1p
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ScienceDirect Free and Delayed Access Journal
  dbid: IXB
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWqHhAXxKdYCmgO3FC0ie3YCbe2oqqQygUq7S2yHYcGsdkqWaj6J_lNzNjOilw4cNnNep3Yykxm7Jk3L4y9M6LSPm9FJr3GD9fKrCrKNhOyFLnR1qma6p2vPqvLa_lpU26O2PlcC0OwymT7o00P1jq1rNPdXN_2_foL55SK0Wh6A5EZbYGI25OK-DZnhzgL0ann4cU71D-jE1LtTIR5jVtHtKBcUEPNxcI_BRr_hZtaIif_ckUXj9mjtIaE0zjNJ-zID0_Zg6uUJX_GfsdIQQj8QT8ArvFgroAE4rvo_BQz8BPsOiDGiJEgA6iK8AMffkhZG-hQSXZ36NzggEcHCtxCQHJRHSVsqXrJ3dxv8Xjajzv6pmQAoNEfDR0RzhV--Sng72g6BhKZa7xW5JLuHUzYAe9JP32AU3A0fkxoPGfXFx-_nl9m6b0NmZNK7bPCeEs7LZ0brzi3Aq1qrW3R5apTrVBaSl-1WnrlVWvLUgsred5ag1rSGc_FC3Y87Ab_kkGhi1ZKK70pcZ_ofZXX3rWddU4Jg4Z8xd7P0mpuIz1HM-PWvjck24Zk20TZrtgZCfTQk6i1Q8Nu_NYk3WpwQeXLVlJ6GCfq6tpwayu0Uw6duVPFipWzOjQLTcVL9f8cvFrozmIWy3-G_iYQfeN2nfNK1a_-c8gT9pB-xYjRa3a8H3_6N7iG2tu34SH5A8YKILs
  priority: 102
  providerName: Elsevier
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9VAEF5qBfFFvOLRKvPgm0SS3c0mEaRUsRTh-OSBvoW9xUZ6kpocL_2T_iZnsptqoAi-5M5mk5mdmd2Z-YaxF1qUhU-dSKQvcGOdTMosd4mQuUh1YayqKN95_VGdbOSH0_x0j83ljuIPHK-d2lE9qc1w_urn18tDHPBv_sRqDVtL2J5c0AU0WW6wm1wKSRy_jub-JJkp63MqwsM5FTVA9RrzaK5vZqGrJkj_hcpaRlH-pZaO77I70Z6Eo8AA99ie7-6zW-voMX_AfoVVg2kRENoO0N6DORsSCPui8WPwxo_QN0DoEQOFDyBbwjkKAogeHGiQYfofqOjgKjYdaBEXpqguyqmELWUy2bPLLR6Pu6GnPTkGABXAoOmIYl7hux-nWDzqjoYI7BraCrjSrYURH8B_0o6v4QgsvT84Nx6yzfH7T-9OkljDIbFSqV2SaW9o1lWk2ivOjUAJWxUma1LVKCdUIaUvXSG98sqZPC-EkTx1RiPHNNpz8Yjtd33nHzPIisxJaaTXOc4ZvS_TylvXGGuV0CjUV-zlTK36IkB11HMM25eaaFsTbetA2xV7SwS9epJgtqcL_fC5jqO2RuPK506Sqxg7aqtKc2NKlFkWFbtV2YrlMzvU0WIJlgg21f7z5eWCdxa9WN7p2rMJ9Bun7pyXqnryX1_5lN2ms7BmdMD2d8M3_wytqJ15Pg2N389VIKo
  priority: 102
  providerName: Scholars Portal
Title Improvement in the clinical manifestations of interstitial lung disease following treatment with placental mesenchymal stromal cell extracellular vesicles in a patient with systemic sclerosis: A case report
URI https://dx.doi.org/10.1016/j.rmcr.2023.101923
https://pubmed.ncbi.nlm.nih.gov/PMC10622869
https://doaj.org/article/317e5d43580744c99a2bb8963c801c61
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb5VAEN-0NTFejJ_xWX2ZgzdDH7DLAt7aF5tq8qoHm7x4IbvLYmkKNPC08Z_0b3JmF5py8eBlIXwsE2aYmZ35zcDYO8Wz1IYlD4RNcTClCLIoKQMuEh6qVBuZU73z5lyeXYjP22S7x-RUC-NA-0bXR-11c9TWlw5bedOY1YQTW33drHEZE8eZzFf7bD_l_N4a3elfqu1M4rFCxoO5-sZQ88-Y04E85jMr5Jr1z4zRHB95z-CcPmGPR08Rjj1FT9mebZ-xh5sxF_6c_fHxABfeg7oF9ORgqnME6mpR2cHn2QfoKqC-ED0BA1Dg4Bo_cRhzM1ChKHS3aMLgDnUOFJ4Fh9eiakloqEbJXP5ucH_Y9R1tKeQPqNp7RXuEZoVfdnBvj8hRMLZs9XP5jtG1gQEvwHdSDx_gGAw936ctXrCL04_f1mfB-HeGwAgpd0GkrKb1VBoqi-zQHHVnnuqoCmUlSy5TIWxWpsJKK0udJCnXIg5LrVAWKmVj_pIdtF1rXzGI0qgUQgurElwNWpuFuTVlpY2RXKG6XrD3E7eKG9-Eo5jQaVcF8bYg3haetwt2Qgy9u5IaaLsDXf-jGMWoQLfJJqWgJDASavJcxVpnqI0MmmwjowVLJnEoRl_E-xg4Vf3Ph2cz2ZlRMT-D0u3aeU_S_Pr_bz1kj4gGHxp6ww52_U_7Fp2lnV66IAOOn7YnOG5EtmQPztfbL9-X7qv5C-bjIng
link.rule.ids 230,315,733,786,790,870,891,2115,3525,24346,27955,27956,45907,53825,53827
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIgEXxFMszzlwQ9EmtuMk3NqKaoFuL7TS3iLbcWgQm1TJAuJP9jd1JnZW5MKBSxLZSWxlJjOe12fG3mmRZy6uRCRdhgdbyShP0ioSMhWxzoxVBdU7r8_V6lJ-3qSbA3Yy1cJQWmWQ_V6mj9I6tCzD11xeN83yK-cUislQ9I5AZmgC3ZEp2npUxbc53jtaCE89HnfeoQcieiIUz_g8r35rCReUC2oouJgpqBHHf6an5qmTf-mi04fsQVhEwpGf5yN24NrH7O46hMmfsBvvKhg9f9C0gIs8mEoggQAvajf4EPwAXQ0EGdFTzgDyIvzAvx9C2AZq5JLuN2o32CekA3luYUzlokJK2FL5kr36s8XrYdd3dKZoAKDU7zVdUaIr_HLDmIBH09EQ0Fz9uzyYdGNhwBvwmzTDBzgCS-P7iMZTdnn68eJkFYWNGyIrldpFiXaGTK0s1k5xbgSK1SIzSR2rWlVCZVK6vMqkU05VJk0zYSSPK6ORTWrtuHjGDtuudc8ZJFlSSWmk0ykais7lceFsVRtrldAoyRfs_USt8trjc5RT4tr3kmhbEm1LT9sFOyaC7u8kbO2xoeu_lYG5SlxRubSSFB_Gidqi0NyYHAWVRW1uVbJg6cQO5YxV8VXNPwfPZ7wzm8W8p22uRqRvtNc5z1Xx4j-HfMvurS7WZ-XZp_MvL9l96vHuo1fscNf_dK9xQbUzb8Yf5hZReCPg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkSouvBHhOQduyIntXa9tbqUQlUeqHqhUiYO1L1ND40S2C4IfyW9ixmtXNQcOvcSWvVmPnc87szvffGHspeJZ6kLLA-FS_DBWBFmU2ICLhIcq1UbmVO-8OpQHx-LDSXIysCrbgVZZG13N67P1vK5Oe27ldm0WI09scbTax2lMHGcyX2xtubjObuBLG6eXZur9KEwVnkk81Ml4SlezNiQBGnM6kMd84ot6yf6JS5qyJC-5neVt9mU02LNNvs_POz03v__RcrzaHd1ht4ZoFPZ8m7vsmqvvsd3VkG-_z_74NYd-CRGqGjBahLGWEkg5o3Stz-W3sCmBtCcaIh8gqOEMhxEY8j9QItw2P9FNwgWzHWgJGHpOGFVkwprqoMzprzXut12zoS2lFQDdR6Nojxiz8MO1_f2QOQoGWVjfl1elrgy02ACfeNW-hj0wdH2fGnnAjpfvPu8fBMM_QARGSNkFkXKa5mxpqBw-IM1xfM5THZWhLKXlMhXCZTYVTjppdZKkXIs4tFoh3krlYv6Q7dSb2j1iEKWRFUILpxKccTqXhbkzttTGSK7QJczYqxELxdYLfRQjA-5bQcgpCDmFR86MvSG4XLQkke7-wKb5Wgw_bIGhmUusoEQzGmryXMVaZzjiGQwLjIxmLBnBVgzxjo9jsKvqvxfPJsicWDE9g3jrJcNHfD2--ldfsN2jt8vi0_vDj0_YTTLHr0Q9ZTtdc-6eYWzW6ef9S_gXQBJCmQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improvement+in+the+clinical+manifestations+of+interstitial+lung+disease+following+treatment+with+placental+mesenchymal+stromal+cell+extracellular+vesicles+in+a+patient+with+systemic+sclerosis%3A+A+case+report&rft.jtitle=Respiratory+medicine+case+reports&rft.au=Assar%2C+Shirin&rft.au=Mohammadzadeh%2C+Dena&rft.au=Norooznezhad%2C+Amir+Hossein&rft.au=Payandeh%2C+Mehrdad&rft.date=2023-01-01&rft.issn=2213-0071&rft.eissn=2213-0071&rft.volume=46&rft.spage=101923&rft_id=info:doi/10.1016%2Fj.rmcr.2023.101923&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_rmcr_2023_101923
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2213-0071&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2213-0071&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2213-0071&client=summon